vs

Side-by-side financial comparison of BLACKLINE, INC. (BL) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $183.2M, roughly 1.1× BLACKLINE, INC.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 2.7%, a 0.0% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 8.1%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 7.9%).

BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

BL vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.1× larger
IRTC
$208.9M
$183.2M
BL
Growing faster (revenue YoY)
IRTC
IRTC
+19.0% gap
IRTC
27.1%
8.1%
BL
Higher net margin
IRTC
IRTC
0.0% more per $
IRTC
2.7%
2.7%
BL
More free cash flow
BL
BL
$11.6M more FCF
BL
$26.1M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
7.9%
BL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BL
BL
IRTC
IRTC
Revenue
$183.2M
$208.9M
Net Profit
$4.9M
$5.6M
Gross Margin
75.2%
70.9%
Operating Margin
3.7%
1.1%
Net Margin
2.7%
2.7%
Revenue YoY
8.1%
27.1%
Net Profit YoY
-91.3%
518.5%
EPS (diluted)
$0.07
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BL
BL
IRTC
IRTC
Q4 25
$183.2M
$208.9M
Q3 25
$178.3M
$192.9M
Q2 25
$172.0M
$186.7M
Q1 25
$166.9M
$158.7M
Q4 24
$169.5M
$164.3M
Q3 24
$165.9M
$147.5M
Q2 24
$160.5M
$148.0M
Q1 24
$157.5M
$131.9M
Net Profit
BL
BL
IRTC
IRTC
Q4 25
$4.9M
$5.6M
Q3 25
$5.3M
$-5.2M
Q2 25
$8.3M
$-14.2M
Q1 25
$6.1M
$-30.7M
Q4 24
$56.4M
$-1.3M
Q3 24
$17.2M
$-46.2M
Q2 24
$76.7M
$-20.1M
Q1 24
$10.8M
$-45.7M
Gross Margin
BL
BL
IRTC
IRTC
Q4 25
75.2%
70.9%
Q3 25
75.1%
71.1%
Q2 25
75.2%
71.2%
Q1 25
75.5%
68.8%
Q4 24
75.6%
70.0%
Q3 24
75.2%
68.8%
Q2 24
74.9%
69.9%
Q1 24
75.2%
66.3%
Operating Margin
BL
BL
IRTC
IRTC
Q4 25
3.7%
1.1%
Q3 25
4.3%
-4.4%
Q2 25
4.4%
-10.0%
Q1 25
2.1%
-20.5%
Q4 24
3.7%
-2.5%
Q3 24
5.0%
-34.1%
Q2 24
1.4%
-15.5%
Q1 24
1.1%
-28.9%
Net Margin
BL
BL
IRTC
IRTC
Q4 25
2.7%
2.7%
Q3 25
3.0%
-2.7%
Q2 25
4.8%
-7.6%
Q1 25
3.6%
-19.3%
Q4 24
33.3%
-0.8%
Q3 24
10.4%
-31.3%
Q2 24
47.8%
-13.6%
Q1 24
6.9%
-34.6%
EPS (diluted)
BL
BL
IRTC
IRTC
Q4 25
$0.07
$0.18
Q3 25
$0.09
$-0.16
Q2 25
$0.13
$-0.44
Q1 25
$0.10
$-0.97
Q4 24
$0.79
$-0.03
Q3 24
$0.27
$-1.48
Q2 24
$0.22
$-0.65
Q1 24
$0.17
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BL
BL
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$390.0M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$332.3M
$152.7M
Total Assets
$1.8B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BL
BL
IRTC
IRTC
Q4 25
$390.0M
$583.8M
Q3 25
$419.9M
$565.2M
Q2 25
$459.1M
$545.5M
Q1 25
$479.5M
$520.6M
Q4 24
$885.9M
$535.6M
Q3 24
$725.3M
$522.0M
Q2 24
$616.6M
$561.5M
Q1 24
$331.4M
$569.1M
Stockholders' Equity
BL
BL
IRTC
IRTC
Q4 25
$332.3M
$152.7M
Q3 25
$328.3M
$121.9M
Q2 25
$414.0M
$103.7M
Q1 25
$417.9M
$86.7M
Q4 24
$446.7M
$90.9M
Q3 24
$367.9M
$71.8M
Q2 24
$325.8M
$99.2M
Q1 24
$279.8M
$90.3M
Total Assets
BL
BL
IRTC
IRTC
Q4 25
$1.8B
$1.0B
Q3 25
$1.7B
$995.2M
Q2 25
$1.8B
$964.0M
Q1 25
$1.8B
$926.1M
Q4 24
$1.8B
$931.4M
Q3 24
$1.7B
$909.7M
Q2 24
$1.9B
$919.2M
Q1 24
$2.1B
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BL
BL
IRTC
IRTC
Operating Cash FlowLast quarter
$26.7M
$26.2M
Free Cash FlowOCF − Capex
$26.1M
$14.5M
FCF MarginFCF / Revenue
14.2%
6.9%
Capex IntensityCapex / Revenue
0.3%
5.6%
Cash ConversionOCF / Net Profit
5.46×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$161.5M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BL
BL
IRTC
IRTC
Q4 25
$26.7M
$26.2M
Q3 25
$63.8M
$34.9M
Q2 25
$32.3M
$27.7M
Q1 25
$46.7M
$-7.9M
Q4 24
$43.8M
$19.2M
Q3 24
$55.9M
$24.3M
Q2 24
$40.7M
$11.8M
Q1 24
$50.4M
$-52.0M
Free Cash Flow
BL
BL
IRTC
IRTC
Q4 25
$26.1M
$14.5M
Q3 25
$63.3M
$20.1M
Q2 25
$31.4M
$17.3M
Q1 25
$40.8M
$-17.3M
Q4 24
$43.0M
$12.4M
Q3 24
$55.5M
$15.5M
Q2 24
$40.0M
$3.4M
Q1 24
$50.1M
$-61.8M
FCF Margin
BL
BL
IRTC
IRTC
Q4 25
14.2%
6.9%
Q3 25
35.5%
10.4%
Q2 25
18.2%
9.3%
Q1 25
24.4%
-10.9%
Q4 24
25.4%
7.5%
Q3 24
33.5%
10.5%
Q2 24
24.9%
2.3%
Q1 24
31.8%
-46.8%
Capex Intensity
BL
BL
IRTC
IRTC
Q4 25
0.3%
5.6%
Q3 25
0.3%
7.7%
Q2 25
0.6%
5.6%
Q1 25
3.6%
5.9%
Q4 24
0.4%
4.2%
Q3 24
0.2%
6.0%
Q2 24
0.4%
5.7%
Q1 24
0.2%
7.4%
Cash Conversion
BL
BL
IRTC
IRTC
Q4 25
5.46×
4.70×
Q3 25
12.07×
Q2 25
3.90×
Q1 25
7.72×
Q4 24
0.78×
Q3 24
3.24×
Q2 24
0.53×
Q1 24
4.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BL
BL

Subscription And Circulation$173.2M95%
Technology Service$10.0M5%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons